SCHEMBL2932642

SCHEMBL2932642

Cc1cc(CN2CCN(C)CC2)ccc1CCc1c(C)ncc(C#N)c1Nc1ccc2[nH]ccc2c1C

nearest known ligand 0.62

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 20/20 0.62
PRKCD Q05655 19/20 0.62
PRKCB P05771 1/20 0.59
LCK P06239 1/20 0.59
LYN P07948 1/20 0.59
PRKCH P24723 1/20 0.59
PRKCE Q02156 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932167 0.91 PRKCQ (0.69) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2928638 0.84 PRKCQ (0.68) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2928640 0.84 PRKCQ (0.68) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2934168 0.82 PRKCQ (0.66) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2934165 0.82 PRKCQ (0.66) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2980924 0.80 PRKCQ (0.79) PRKCQPRKCDPRKCHPRKCE
SCHEMBL2980922 0.80 PRKCQ (0.79) PRKCQPRKCDPRKCHPRKCE
SCHEMBL2933949 0.80 PRKCQ (0.68) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2929219 0.80 PRKCQ (0.81) PRKCQPRKCDPRKCBLCKLYN
SCHEMBL2937345 0.80 PRKCQ (0.83) PRKCQPRKCDPRKCBLCKLYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229377-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS Wyeth LLC (US) 2010-09-22 EP claimed
WO-2009076602-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS WYETH (US) 2009-06-18 WO claimed
EP-2229377-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS Wyeth LLC (US) 2010-09-22 EP disclosed
WO-2009076602-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS WYETH (US) 2009-06-18 WO disclosed